Can You Take Berberine and Inositol Together? What the Trials Tested
In this article
- Has any trial tested berberine and inositol together?
- What was each measured for on its own?
- Who must not take berberine, and does inositol change that?
- What about metformin with either, or with both?
- Do berberine and inositol interact with each other?
- How did the trials take each one?
- Which should you choose?
- What we don't know
- Frequently asked questions
No trial has tested berberine and inositol together, so nobody can say what the pair does. The one study that ran them side by side in separate groups of women with polycystic ovary syndrome (PCOS, now called PMOS by the NHS), a 2022 Indian trial of 129 women, was retracted on 2 November 2026 for errors in its reported data, including the sample size, and is not counted here; what remains is a 2021 network analysis that compared the two only indirectly and a 2026 observational series of 148 women that draws no conclusion on which works better.1, 20, 21 Berberine is not taken in pregnancy, breastfeeding or when trying to conceive; inositol has no such rule, though the guideline says its safety in fertility treatment is not known.2, 3 This page sits between the Wellgard berberine guide and the Wellgard inositol guide.
Evidence at a glance
- Trials: none of the pair; the one randomised three-arm trial that ran berberine, myo-inositol and metformin in separate groups was retracted in November 2026 and is not counted.
- Largest study counted: a 2026 series of 148 women with PCOS in routine care, six months, allocation not random.
- Strongest measured outcome: in that series fasting insulin and insulin resistance fell within the berberine group and within the myo-inositol group; after adjustment for the groups' different starting points, no between-group difference remained on the main metabolic measures.
- Not tested: the pair in the same woman, for any outcome.
Sources checked on 3 November 2026.
Has any trial tested berberine and inositol together?
No. A PubMed search on 3 November 2026 found no randomised trial of berberine with myo-inositol in PCOS, and neither the 30 inositol trials pooled for the 2023 guideline nor the 12 berberine trials pooled in 2019 has a combination group.4, 5 The only placebo-controlled trial that gave both substances was of a five-ingredient blend (berberine 200 mg, inositol 300 mg, curcumin 200 mg, banaba 40 mg and 100 micrograms of chromium a day) in 148 adults with raised fasting glucose, not PCOS, for three months, supported by the product's maker, which also employed one author; it cannot separate the two ingredients, and the one 2026 study of the pair itself was in mice.22, 23
The one trial that ran them side by side, in separate groups, was a 2022 Indian trial that randomised women with PCOS to berberine, myo-inositol or metformin for 12 weeks and analysed 129 of them: on 2 November 2026 the journal's editor retracted it "due to errors in the reported data, including the sample size", the underlying data could not be verified, and the corresponding author agreed. Nothing from it is counted here.1
Two comparisons are left. A 2021 network analysis of 22 randomised trials and 1,079 women with PCOS (Chinese state science funding) compared metformin, thiazolidinediones, inositols and berberine, but only indirectly: no trial in it set berberine against inositol.20 A 2026 retrospective series from Bulgaria followed 148 women with PCOS who had completed six months on myo-inositol 1,000 mg twice a day (38 women), metformin (52), berberine 500 mg twice a day (28) or metformin with berberine (30) in routine care: each group improved on several of its own measures, including fasting insulin and insulin resistance on both berberine and myo-inositol, but the groups differed at the start, nobody was randomised, and after adjustment no difference between groups remained on the main metabolic measures, so the authors draw no conclusion on which works better (no external funding).21
What was each measured for on its own?
Both records are three-month blood and body measures in women with PCOS, which the NHS calls polyendocrine metabolic ovarian syndrome; trials say PCOS.6, 7
| Measure | Berberine | Myo-inositol |
|---|---|---|
| Trials pooled | 12 randomised trials, pooled in 20195 | 30 trials, 2,230 women, reviewed for the 2023 guideline (19 pooled)4 |
| Against metformin | Waist 2.74 cm smaller (3 trials, 197 women); BMI no different (4 trials, 262)5 | Metformin may improve waist-to-hip ratio and hirsutism more; fewer gut side effects on myo-inositol (6 trials, 382 women)4 |
| Against placebo | Total testosterone lower (8 trials, 577 women); LH:FSH ratio lower (3 trials, 179)5 | Benefit on some metabolic measures; evidence "limited and inconclusive"4 |
| Periods and fertility | Live birth similar to placebo or metformin, lower than with letrozole (relative risk 0.61); periods not a main outcome in any trial5 | Guideline: "limited clinical benefits including in ovulation, hirsutism or weight"; in PCOS infertility, "experimental therapy"3 |
| Gut side effects | No more frequent than placebo (3 trials, 567 women)5 | Likely fewer than on metformin, "typically mild and self-limited"4 |
The guideline says inositol "could be considered" in PCOS, "noting limited harm, potential for improvement in metabolic measures, yet with limited clinical benefits", and that "specific types, doses or combinations of inositol cannot currently be recommended".3 Both are food supplements with no authorised health claim in Great Britain; the figures belong to the trials, and none rests on a retracted inositol trial. Berberine for PCOS has the berberine trials.
Who must not take berberine, and does inositol change that?
Berberine displaces bilirubin from its carrier protein, which is why it is avoided in pregnancy, breastfeeding and infancy:8 in a jaundiced newborn the freed bilirubin can damage the brain;2 the French food-safety agency's 2019 opinion also advises children, adolescents and people with diabetes or liver or heart conditions not to take berberine supplements.19 No trial has included a pregnant or breastfeeding woman; how much passes into milk is unknown.9 The NHS says "Not all 'natural' remedies or complementary therapies are safe in pregnancy", advises against herbal remedies when trying to get pregnant, and for breastfeeding "not enough is known about herbal remedies to guarantee they're safe".10, 11 Babies with G6PD deficiency can suffer severe red-cell breakdown from it.12
PCOS makes the rule harder to keep, because the NHS lists irregular periods or long gaps between periods among its symptoms, so a late period is not the signal it is for other women.7 Inositol alongside changes none of this, and the guideline says inositol's "side effects and safety are not known" in fertility settings.3 So anyone who might become pregnant leaves berberine out, with or without inositol, and anyone in fertility treatment declares both to the clinic; berberine for women covers pregnancy, breastfeeding and menopause.
What about metformin with either, or with both?
Metformin is, in the NHS's words, "a type 2 diabetes medicine to help tiredness and weight problems" that may be prescribed for PMOS.7 No study has measured metformin blood levels in anyone taking berberine. Inositol added to metformin has been pooled: across six randomised trials of 388 women over three to six months, regular cycles were 1.56 times as likely on the combination (interval 1.01 to 2.41) and the hirsutism score lower, while BMI, fasting glucose and insulin resistance did not differ significantly.13 No trial has given all three together. The NHS metformin page asks you to tell your doctor or pharmacist "if you're taking any other medicines, herbal remedies, vitamins or supplements"; nobody pauses or stops metformin for a supplement.14 Inositol and metformin, what the trials compared has the head-to-head trials; what medicines interact with berberine covers the rest.
Do berberine and inositol interact with each other?
No study has looked, in either direction. Its known interactions are with medicines: in 52 kidney-transplant recipients, three months of berberine left ciclosporin levels 29% higher than in 52 without it, and two weeks at 900 mg a day reduced the activity of liver enzymes CYP3A4, CYP2D6 and CYP2C9 in healthy men; that enzyme effect builds over days and does not switch off between doses.15, 16 Those enzymes clear medicines, not inositol. The plausible overlap is glucose: in the 2026 series both lowered fasting insulin and insulin resistance within their own groups, berberine lowers glucose measures in its pooled diabetes trials, and the guideline review's small inositol pool lowered insulin resistance at very low certainty, so anyone on a glucose-lowering medicine asks the diabetes team before adding either.4, 17, 21 In 37 trials of 3,048 people with type 2 diabetes, berberine alone or beside glucose-lowering tablets did not increase hypoglycaemia (relative risk 0.48, not significant).17 Berberine side effects and who should avoid it has the gut rates by dose.
How did the trials take each one?
Separately. The 2026 series used berberine 500 mg and myo-inositol 1,000 mg, each twice a day, for six months; the diabetes trials mostly used 900 to 2,400 mg a day in two or three doses with meals, and the PCOS inositol trials usually 2 to 4 g a day over three to six months.21, 13, 17 Those are trial amounts, not a recommendation; no schedule for the pair exists.
Which should you choose?
Not ranked here; what each was measured for, and the pregnancy rule, settle it. Anyone who might become pregnant, is breastfeeding or trying to conceive leaves berberine out; the guideline lists inositol as an option with limited clinical benefit while keeping lifestyle change and metformin at the centre.3 PCOS is a GP diagnosis, and no supplement replaces a prescribed medicine.
What we don't know
- No trial has given berberine and inositol to the same women, so the pair's effect, safety and dose are unknown.
- No study has measured whether either changes the other's blood levels.
- The one head-to-head trial was retracted in 2026; the only remaining side-by-side comparison is observational, six months, in one country, and has not been repeated.
- No berberine trial has included a pregnant woman, and the guideline says inositol's side effects and safety are not known in fertility settings.
Frequently asked questions
Is berberine or inositol better for PCOS?
Neither has been shown better. The one trial that compared them was retracted in November 2026; the 2026 observational series found no between-group difference on the main metabolic measures after adjustment; the guideline review calls inositol's evidence "limited and inconclusive".1, 21, 4
Can you take berberine and inositol with metformin?
No trial has tested the three together, and no study has measured metformin levels with berberine; inositol added to metformin was pooled from six trials of 388 women.13
Can you take inositol while trying to conceive?
The guideline calls inositol "experimental therapy" for PCOS-related infertility, and NICE's draft guideline for the UK (consultation closed August 2026; publication expected January 2027) puts it plainly, "advise that inositol is not effective for fertility problems", so the fertility clinic, not a supplement, decides; berberine is not taken when trying to conceive.3, 18, 2
How long did the trials run?
Six months for the 2026 series, three to six months for the inositol-plus-metformin trials.21, 13
Sources
- Mishra N et al. Cureus 2022. Randomised open-label trial, 129 women reported, 12 weeks. RETRACTED 2 November 2026 by the journal's editor-in-chief "due to errors in the reported data, including the sample size"; not counted. PubMed 35251851; retraction notice PubMed 42974326
- Chan E. Biology of the Neonate 1993. Laboratory and rat study. PubMed 8513024
- Teede HJ et al. Human Reproduction 2023. International guideline, 254 recommendations. PubMed 37580037
- Fitz V et al. Journal of Clinical Endocrinology and Metabolism 2024. Systematic review for the 2023 guideline, 30 trials included (19 pooled), 2,230 women. PubMed 38163998
- Xie L et al. Evidence-Based Complementary and Alternative Medicine 2019. Pooled analysis of 12 randomised trials. PubMed 31915452
- Teede HJ et al. Lancet 2026. Consensus statement, 14,360 survey respondents. PubMed 42119588
- NHS. Polyendocrine metabolic ovarian syndrome (PMOS), previously PCOS. Page last reviewed 30 June 2026. nhs.uk/conditions/polyendocrine-metabolic-ovarian-syndrome-pmos
- Rad SZK et al. Iranian Journal of Basic Medical Sciences 2017. Narrative toxicology review. PubMed 28656087
- Drugs and Lactation Database (LactMed). Goldenseal. Database record, revised 15 May 2025. PubMed 30000926
- NHS. Medicines in pregnancy. Page last reviewed 5 September 2022 (review overdue; re-read 12 October 2026). nhs.uk/pregnancy/keeping-well/medicines
- NHS. Breastfeeding and medicines. Page last reviewed 7 May 2026. nhs.uk/conditions/baby/breastfeeding-and-bottle-feeding/breastfeeding-and-lifestyle/medicines
- Ho NK. Singapore Medical Journal 1996. Review of 20 reports. PubMed 9104069
- Kelly FA et al. Endocrine 2025. Pooled analysis of 6 randomised trials, 388 women, 3 to 6 months. PubMed 39331347
- NHS. Metformin. Page last reviewed 5 August 2026. nhs.uk/medicines/metformin
- Wu X et al. European Journal of Clinical Pharmacology 2005. Randomised trial, 104 transplant recipients, 3 months. PubMed 16133554
- Guo Y et al. European Journal of Clinical Pharmacology 2012. Randomised crossover study, healthy men, 2 weeks. PubMed 21870106
- Xie W et al. Frontiers in Pharmacology 2022. Pooled analysis of 37 randomised trials, 3,048 people. PubMed 36467075
- NICE. Polyendocrine metabolic ovarian syndrome (PMOS): assessment and management. Draft guideline for consultation, July 2026; consultation closed 11 August 2026; publication expected 27 January 2027. GID-NG10436, nice.org.uk/guidance/indevelopment/gid-ng10436
- ANSES. Opinion on the safety of berberine-containing plants in food supplements, saisine 2018-SA-0095. Agency opinion, in French, 1 August 2019. anses.fr.
- Zhao H et al. Reproductive Health 2021. Network pooled analysis of 22 randomised trials, 1,079 women; no direct berberine-against-inositol trial; Chinese state science funding. PubMed 34407851
- Yanachkova V et al. Journal of Clinical Medicine 2026. Retrospective observational series, 148 women, 6 months, allocation not random; no external funding. PubMed 42941281
- Derosa G et al. Diabetes, Metabolic Syndrome and Obesity 2020. Randomised placebo-controlled trial of a five-ingredient blend, 148 adults with raised fasting glucose, 3 months; supported by the product's maker, one author employed there. PubMed 32184644
- Ge J et al. Cell Proliferation 2026. Mouse study of the pair; Chinese state science funding, one author at a biotechnology company. PubMed 41761674
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.